Financhill
Back

CRISPR Therapeutics AG Quote, Financials, Valuation and Earnings

CRISPR Therapeutics AG Price Quote

$49.34
-1.06 (-2.1%)
(Updated: November 26, 2024 at 5:55 PM ET)

CRISPR Therapeutics AG Key Stats

Buy
54
CRISPR Therapeutics AG (CRSP) is a Buy

Day range:
$48.89 - $51.73
52-week range:
$43.42 - $91.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.22%

Volume:
2.2M
Avg. volume:
1.7M
1-year change:
-27.97%
Market cap:
$4.3B
Revenue:
$370M
EPS:
$-2.8

How Much Does CRISPR Therapeutics AG Make?

Data Unavailable

Is CRISPR Therapeutics AG Growing As A Company?

Data Unavailable

CRISPR Therapeutics AG Stock Price Performance

What Is CRISPR Therapeutics AG 52-Week High & Low?

CRISPR Therapeutics AG Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy CRISPR Therapeutics AG?

Is CRISPR Therapeutics AG Cash Flow Positive?

  • What Is CRSP Cash Flow From Operations?
    Cash flow from operations (TTM) is -$188.8M
  • What Is CRISPR Therapeutics AG’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $354M
  • What Is CRISPR Therapeutics AG’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$467.8M

CRISPR Therapeutics AG Return On Invested Capital

Data Unavailable

CRISPR Therapeutics AG Earnings Date & Stock Price

CRISPR Therapeutics AG Competitors

CRISPR Therapeutics AG Dividend Yield

CRISPR Therapeutics AG Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 28.11%
Revenue: 0% -91.56%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 11
Sell Recommendations: 2
Price Target: 81.54
Upside from Last Price: 61.79%

Major Shareholders

  • How many CRSP shares are owned by institutional investors?
    99M CRSP shares are owned by institutional investors
  • How many CRSP shares are owned by insiders?
    1.6M CRSP shares are owned by insiders